Mark A. Rodgers

Senior Research Specialist


Mark Rodgers

Contact

412-648-8086
Fax: 412-648-8917

8th Floor Biological Science Tower III

3501 Fifth Avenue

Pittsburgh, PA 15261

Education

MS in Cell Biology and Molecular Genetics, University of Maryland

BS in Biochemistry and Molecular Biology, Pennsylvania State University

Research Lab Affiliation

Areas of Interest

Tuberculosis research - Immunology, Vaccine Development, Drug Treatment

Publications

Lin, P. L; Dietrich, J; Tan, E; Abalos, R. M; Burgos, J; Bigbee, C; Bigbee, M; Milk, L; Gideon, H. P; Rodgers, M; Cochran, C; Guinn, K. M; Sherman, D. R; Klein, E; Janssen, C; Flynn, J. L; and Andersen, P. (2012) The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection. J Clin Invest. 122: 303-314. |  View Abstract

Lin, P. L; Rodgers, M; Smith, L; Bigbee, M; Myers, A; Bigbee, C; Chiosea, I; Capuano, S. V; Fuhrman, C; Klein, E; and Flynn, J. L. (2009) Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model. Infect Immun. 77: 4631-4642. |  View Abstract